Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Intercont (Cayman) Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
32.4
25.5
25.1
Cost of revenue
18.1
18.2
17.3
Gross profit
14.4
7.35
7.84
Research and development
0.6
0.62
General and administrative
0.88
1.67
2.31
Operating expenses
0.88
2.27
2.94
Operating income
13.5
5.08
4.9
Interest expense
2.72
2.7
1.91
Interest income
0.19
0.31
0
Other non-operating income
-2.61
-1.94
-1.8
Pre-tax income
10.9
3.14
3.1
Net income to minority interests
0.02
Net income
10.9
3.14
3.1
EBITDA
17
8.73
8.6
EPS, basic
0.40
0.10
0.10
EPS, diluted
0.40
0.10
0.10
Shares, basic (weighted)
24.5
24.6
25.4
Shares, diluted (weighted)
24.5
24.6
25.4
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
3.42
3.75
5.65
Short-term investments
10.3
Receivables
0.26
0.29
Other current assets
0.56
0.79
Total current assets
5.11
18.4
Property, plant and equipment
0
0.01
Lease right-of-use assets
4.59
1.56
Total assets
65.1
70.8
Accounts payable
1.04
1.03
Accrued liabilities
0.31
1.11
Deferred revenue
0.19
0.21
0.43
Short-term debt
1.66
1.66
Total current liabilities
35.4
34.1
Long-term debt
2.85
1.25
Lease liabilities
1.57
Total liabilities
54.2
46
Total debt
4.51
2.91
Paid-in capital
3.02
12.5
Retained earnings
9.26
12.4
Shareholders' equity
10.9
24.8
Total equity
18
10.9
24.8
Total liabilities and equity
65.1
70.8
Shares outstanding
25
26.7
Cash flow statement
FY2023
FY2025
FY2025
Net income
10.9
3.14
3.1
Depreciation and amortization
3.46
3.65
3.7
Change in receivables
-0.1
-0.16
0.66
Change in payables
0.09
0.13
-0.55
Cash from operations
13.6
6.48
7.4
Capital expenditures
-12
-0.66
-1.05
Purchases of investments
-10.2
Cash from investing
-24
10.5
-11.3
Debt issued
9.49
Dividends paid
-3.87
-11.8
Cash from financing
3.41
-16.7
5.75
Net change in cash
-7.02
0.34
1.9
Free cash flow
1.57
5.82
6.35
Interest paid
2.31
2.34
1.6
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $4.43 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
31.2%
Gross profit / revenue.
Operating margin
19.5%
Operating income / revenue.
EBITDA margin
34.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
12.4%
Pre-tax income / revenue.
Net margin
12.4%
Net income / revenue.
FCF margin
25.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
29.4%
Cash from operations / revenue.
Return on equity (ROE)
17.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
4.6%
Net income / average total assets.
Return on invested capital (ROIC)
22.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
2.5%
Research and development expense / revenue.
Capex / revenue
4.2%
Capital expenditures / revenue.
D&A / revenue
14.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-1.5%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
6.6%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-3.5%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-1.5%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-1.1%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
0.0%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
14.3%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
9.1%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
127.1%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
8.7%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
3.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.54x
Current assets / current liabilities.
Quick ratio
0.48x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.47x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.12x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
4.1%
Total debt / total assets.
Liabilities / assets
64.9%
Total liabilities / total assets.
Net debt
-$13.0M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
-1.52x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
14.2%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.10
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.10
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.99
Revenue / diluted weighted shares.
FCF per share
$0.25
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.29
Cash from operations / diluted weighted shares.
Book value per share
$0.93
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
36.6x
Market cap / net income. Only when net income is positive.
P/S
4.52x
Market cap / revenue.
P/B
4.58x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
4.58x
Market cap / tangible book value, when positive.
P/FCF
17.9x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
15.3x
Market cap / cash from operations, when positive.
EV/Sales
4.00x
Enterprise value / revenue.
EV/EBIT
20.5x
Enterprise value / operating income, when both are positive.
EV/EBITDA
11.7x
Enterprise value / EBITDA, when both are positive.
EV/FCF
15.8x
Enterprise value / free cash flow, when both are positive.
FCF yield
5.6%
Free cash flow / market cap.
Earnings yield
2.7%
Net income / market cap (the inverse of P/E).
What was Intercont (Cayman) Ltd's revenue in fiscal 2025?
Intercont (Cayman) Ltd reported revenue of $25.1M for fiscal 2025, 1.5% lower than the year before.
Was Intercont (Cayman) Ltd profitable in fiscal 2025?
Yes. Net income was $3.1M, a net margin of 12.4%.
How much free cash flow did Intercont (Cayman) Ltd generate in fiscal 2025?
Cash from operations of $7.4M minus capital expenditures of $1.1M left free cash flow of $6.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.